Compound ID | 2813
Class: Drug efflux pump inhibitor
Spectrum of activity: | Gram-negative |
Details of activity: | Active against Gram-negatives; inhibits AcrAB-TolC activity |
Description: | Synthetic compound derived from identified Salmonella enterica serotype Typhimurium efflux pump modulators (EPM35) with increased potency and high selectivity |
Institute where first reported: | Molecular, Cellular, and Developmental Biology, University of Colorado Boulder, Boulder, Colorado, USA; Cleveland Center for Membrane and Structural Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA; Department of Pharmacology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA |
Year first mentioned: | 2023 |
Development status: | Experimental |
Chemical structure(s): | |||||||||||
|
|
External links: | |
Citation: | https://journals.asm.org/doi/10.1128/mbio.02492-23 |